MedPath

Video Education With Result Dependent dIsclosure

Not Applicable
Recruiting
Conditions
Genetic Testing
Ovarian Cancer
Pancreatic Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Renal Cancer
Melanoma
Sarcoma
Interventions
Behavioral: Genetic Counseling
Behavioral: Video Education
Registration Number
NCT05225428
Lead Sponsor
Dana-Farber Cancer Institute
Brief Summary

The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.

Detailed Description

This study consists of two parts:

* Qualitative assessment:

* This part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review. Participation in the study will be considered complete after the interview is finished. The qualitative assessment study will recruit 20 total participants.

* The data gathered from this study will inform the refinement and adaptation of the VERDI model for the subsequent randomized controlled trial.

* Randomized control trial:

* A randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling in 1000 participants

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1020
Inclusion Criteria
  • Age ≥ 18 years
  • Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
  • Ability to understand spoken or written English or Spanish in a healthcare context
  • Ability to understand and the willingness to sign a written informed consent document
  • Black or Latinx (qualitative assessment study only)
Exclusion Criteria
  • Prior cancer genetic testing
  • Prior germline genetic testing
  • Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
  • Currently pregnant
  • Currently incarcerated

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RCT-Genetic CounselingGenetic CounselingA randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling
QUALITATIVE ASSESSMENTVideo EducationThis part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review. It is expected that about 20 people will take part in this part of the research study. In the larger part of the study that will happen after this part of the study, it is expected 1000 people will participate.
RCT-VERDIVideo EducationA randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling
Primary Outcome Measures
NameTimeMethod
Video Education Acceptability (Qualitative Interview Study)3 Weeks

Pre- and post-test of knowledge of hereditary cancer risk and cancer genetic counseling with qualitative patient interview question domains and instruments to assess understanding of language and imagery of video education as correlated with measures of health literacy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dana Farber Cancer Institute

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath